Endeavor iv trial results

Study record managers: refer to the Data Element Definitions if submitting registration or results information. Talk with your doctor and family members or friends about deciding to join a study.

To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms. Save this study. Warning You have reached the maximum number of saved studies Listing a study does not mean it has been evaluated by the U.

Federal Government. Read our disclaimer for details. Last Update Posted : April 20, Study Description. The purpose of this study is to assess the equivalence in safety and efficacy of the Endeavor Drug Eluting Coronary Stent System when compared to the Taxus Paclitaxel-Eluting Coronary Stent System for the treatment of single de novo lesions in native coronary arteries with a reference vessel diameter RVD of 2.

Results: At follow-up, the ZES group showed significantly greater percentage of neointimal obstruction Neointima-free frame ratio was significantly lower in the ZES group. In overall analysis, whereas the PES group showed positive remodeling during follow-up Federal Government.

Read our disclaimer for details. Last Update Posted : April 20, Publications automatically indexed to this study by ClinicalTrials. Epub Mar The Endeavor IV trial included 1, patients at 80 locations and was randomized to treatment with either the Endeavor or Taxus stent.

Skip to main content. You are here Home. Error message Deprecated function : The each function is deprecated.